Patient access & assistance
Develop pathways for subsidized diagnostic services and support for underserved patients through eligible clinical partners.
Bridging the gap between scientific innovation and equitable access to cancer diagnostics, clinical research and precision healthcare.
Scientific breakthroughs matter most when they reach people who need them. We aim to connect research, clinical institutions and community support to help close gaps in diagnostic access.
Aarogya Jyoti Foundation is building a long-term, partnership-driven approach to more inclusive cancer and precision healthcare in India.
To improve access to timely, affordable and scientifically robust diagnostics through patient assistance, responsible biomarker research, clinical collaborations and strengthened healthcare infrastructure.
To help create an India where income, location or social circumstances do not determine whether a person can benefit from high-quality cancer detection and precision healthcare.
A connected model that combines direct patient benefit with sustainable scientific and clinical capacity.
Develop pathways for subsidized diagnostic services and support for underserved patients through eligible clinical partners.
Support rigorous, clinically relevant research to discover and independently validate biomarkers for cancer and other serious diseases.
Build shared multi-omics and molecular research capabilities with appropriate quality, biosafety and data-management systems.
Work with hospitals, clinicians, research centres and public-health institutions to translate evidence into responsible care pathways.
Our proposed approach connects scientific evidence with clinical decision-making, while keeping qualified healthcare professionals at the centre.
Partner with hospitals and communities to understand diagnostic access gaps.
Conduct ethical, protocol-driven biomarker research and clinical studies.
Assess analytical and clinical performance before wider use.
Support clinician-led deployment and affordable patient pathways where appropriate.
An ambitious five-year development plan, subject to funding, institutional partnerships, approvals and operational readiness.
Build governance systems, secure hospital partnerships, design the central laboratory and initiate the first cancer biomarker programme.
Commission laboratory capabilities, strengthen teams and expand ethically approved research cohorts and analytical workflows.
Advance independent biomarker validation, data quality systems and regional clinical and diagnostic partnerships.
Scale eligible patient assistance, multicentre research and regional access pathways based on evidence and resources.
Evaluate health and access outcomes, strengthen quality systems and establish long-term programme sustainability.
Our indicative five-year financial plan combines major research infrastructure with biomarker programmes, clinical validation, patient access and responsible operations.
We intend to build every programme around patient welfare, ethical research, transparent financial stewardship and independently verifiable outcomes.
Respect informed consent, clinical oversight and appropriate protections for participants.
Apply applicable privacy rules, ethical approvals and appropriate security safeguards.
Use documented, fair-value contracting and independent review of related-party arrangements.
Report programme outputs and validated outcomes accurately, distinguishing goals from results.
Our foundation brings together scientific ambition and a commitment to equitable patient access.
Providing the scientific vision and leadership for Aarogya Jyoti Foundation's mission to connect translational research with accessible healthcare.
ramvinay.pandey@aarogyajyoti.org ↗For patient access enquiries, scientific collaboration, institutional partnerships and CSR conversations, please contact our India office.
Dr. Ram Vinay Pandey, PhD
Founder & CEO
We welcome conversations with hospitals, researchers, philanthropic partners, CSR teams and public institutions interested in expanding equitable access to precision healthcare.
Start a conversation ↗